FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Julia Beiser

Research Profile

Disorders

Physiology

Procedures

Chemicals & Drugs

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
James Brandt; Feng Gao; Mae O Gordon; Michael A Kass; J. Philip Miller; Julia A Beiser
Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.
Feng Gao; Julia A Beiser; Michael A Kass; Stefano Miglior; J Philip Miller; Valter Torri; Mae O Gordon
The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis.
James Brandt; Mae O Gordon; Julia A Beiser; Shan C Lin; Monica Y Alexander; Michael A Kass
Changes in central corneal thickness over time: the ocular hypertension treatment study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Julia Beiser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: James Brandt; Feng Gao; Mae O Gordon; Michael A Kass; J. Philip Miller; Julia A Beiser
Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.
Ophthalmology 2012;119(3):437-42.
2012: Feng Gao; Julia A Beiser; Michael A Kass; Stefano Miglior; J Philip Miller; Valter Torri; Mae O Gordon
The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis.
BMC medical research methodology 2012;12():151.
2008: James Brandt; Mae O Gordon; Julia A Beiser; Shan C Lin; Monica Y Alexander; Michael A Kass
Changes in central corneal thickness over time: the ocular hypertension treatment study.
Ophthalmology 2008;115(9):1550-6, 1556.e1.
2008: Mae O Gordon; Julia A Beiser; Michael A Kass
Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?
Archives of ophthalmology 2008;126(2):280-1.
2007: Steven L Mansberger; Bret A Hughes; Mae O Gordon; Steven D Spaner; Julia A Beiser; George A Cioffi; Michael A Kass
Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study.
Archives of ophthalmology 2007;125(4):454-9.
2007: Mae O Gordon; Valter Torri; Stefano Miglior; Julia A Beiser; Irene Floriani; J. Philip Miller; Feng Gao; Ingrid Adamsons; Davide Poli; Ralph B D'Agostino; Michael A Kass
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.
Ophthalmology 2007;114(1):10-9.
2006: Donald L Budenz; Douglas R Anderson; William J Feuer; Julia A Beiser; Joyce C. Schiffman; Richard K Parrish; Jody R Piltz-Seymour; Mae O Gordon; Michael A Kass
Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study.
Ophthalmology 2006;113(12):2137-43.
2006: David C Herman; Mae O Gordon; Julia A Beiser; Leo T Chylack; Kathleen A Lamping; Oliver D Schein; Joern B Soltau; Michael A Kass
Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study.
American journal of ophthalmology 2006;142(5):800-10.
2005: Linda M Zangwill; Robert N Weinreb; Julia A Beiser; Charles C Berry; George A Cioffi; Anne L Coleman; Gary Trick; Jeffrey M Liebmann; James Brandt; Jody R Piltz-Seymour; Keri A Dirkes; Suzanne Vega; Michael A Kass; Mae O Gordon
Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.
Archives of ophthalmology 2005;123(9):1188-97.
2004: James Brandt; Julia A Beiser; Mae O Gordon; Michael A Kass
Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
American journal of ophthalmology 2004;138(5):717-22.
2004: Anne L Coleman; Mae O Gordon; Julia A Beiser; Michael A Kass
Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.
American journal of ophthalmology 2004;138(4):684-5.
2004: Eve J Higginbotham; Mae O Gordon; Julia A Beiser; Michael V Drake; G Richard Bennett; M R Wilson; Michael A Kass
The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals.
Archives of ophthalmology 2004;122(6):813-20.
2002: Mae O Gordon; Julia A Beiser; James Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J. Philip Miller; Richard K Parrish; M R Wilson; Michael A Kass
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.
Archives of ophthalmology 2002;120(6):714-20; discussion 829-30.
2001: James Brandt; Julia A Beiser; Michael A Kass; Mae O Gordon
Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).
Ophthalmology 2001;108(10):1779-88.
2000: JR Piltz; R Gross; Dong H Shin; Julia A Beiser; David A Dorr; Michael A Kass; Mae O Gordon
Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study.
American journal of ophthalmology 2000;130(4):441-53.